About Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gruppo Italiano Malattie EMatologiche dell'Adulto
6
Clinical Trials at Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano
During the past decade, Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia
2016-04-01
2018-12-01
Unknown status
100
Efficacy and Safety of Bendamustine Plus Rituximab in Chronic Lympocytic Leukemia
2016-02-01
2017-01-01
Completed
494
Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Program
2016-03-01
2018-10-03
Completed
264
Sustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid Leukemia
2016-11-11
2024-02-01
Active, not recruiting
450
D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia
2017-05-31
2021-06-01
Unknown status
60
Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma
2017-11-13
2024-12-01
Recruiting
520
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano
According to Clinical.Site data, the most researched conditions in "Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano" are
"Chronic Lymphocytic Leukemia" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Chronyc Myeloid Leukemia" (1 trials), "Immune Thrombocytopenia" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano" in a lesser frequency.
Clinical Trials Intervention Types at Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano
Most popular intervention types in "Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bendamustine + Rituximab" (1 trials), "Blinatumomab" (1 trials), "Dasatinib" (1 trials), "Eltrombopag" (1 trials) and "Ibrutinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano
The vast majority of trials in "Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano" are
6 trials for "All" genders.
Clinical Trials Status at Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano
Currently, there are NaN active trials in "Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".